<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T18:38:08Z</responseDate>
  <request identifier="oai:figshare.com:article/33999864" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33999864</identifier>
        <datestamp>2026-09-25T17:46:32Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_135</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Data PLOS.&lt;/p&gt;</dc:title>
          <dc:creator>Leonardo Bohorquez Santiago (25111623)</dc:creator>
          <dc:creator>Diana Marcela Devia Narváez (25111626)</dc:creator>
          <dc:creator>Rogelio Ospina Ospina (25111629)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Computational  Biology</dc:subject>
          <dc:subject>proposed protocol comprises</dc:subject>
          <dc:subject>potential bioactive properties</dc:subject>
          <dc:subject>localized dopant source</dc:subject>
          <dc:subject>following key elements</dc:subject>
          <dc:subject>chamber vacuum conditions</dc:subject>
          <dc:subject>targeted characterization techniques</dc:subject>
          <dc:subject>encompassing laser characteristics</dc:subject>
          <dc:subject>uniform thin films</dc:subject>
          <dc:subject>based thin films</dc:subject>
          <dc:subject>metallic copper filaments</dc:subject>
          <dc:subject>ensure effective doping</dc:subject>
          <dc:subject>embedding copper filaments</dc:subject>
          <dc:subject>div &gt;&lt; p</dc:subject>
          <dc:subject>targets :&lt;/ b</dc:subject>
          <dc:subject>thin films</dc:subject>
          <dc:subject>physicochemical characterization</dc:subject>
          <dc:subject>laser ablation</dc:subject>
          <dc:subject>ensure reproducibility</dc:subject>
          <dc:subject>copper doping</dc:subject>
          <dc:subject>work provides</dc:subject>
          <dc:subject>systematic approach</dc:subject>
          <dc:subject>substrate distance</dc:subject>
          <dc:subject>stepwise procedure</dc:subject>
          <dc:subject>resulting coatings</dc:subject>
          <dc:subject>reproducible route</dc:subject>
          <dc:subject>reliable framework</dc:subject>
          <dc:subject>physically modified</dc:subject>
          <dc:subject>papld system</dc:subject>
          <dc:subject>papld ).</dc:subject>
          <dc:subject>novel approach</dc:subject>
          <dc:subject>film growth</dc:subject>
          <dc:subject>exhaustive physicochemical</dc:subject>
          <dc:subject>details regarding</dc:subject>
          <dc:subject>cu films</dc:subject>
          <dc:subject>copper species</dc:subject>
          <dc:subject>controlled co</dc:subject>
          <dc:subject>configuration enables</dc:subject>
          <dc:subject>compositional consistency</dc:subject>
          <dc:subject>complementary publication</dc:subject>
          <dc:subject>biological evaluations</dc:subject>
          <dc:subject>biological assessment</dc:subject>
          <dc:description>&lt;div&gt;&lt;p&gt;This work provides a detailed and reproducible methodology for the fabrication of copper-doped hydroxyapatite (HAp-Cu) thin films on silicon substrates via Plasma-Assisted Pulsed Laser Deposition (PAPLD). The methodology is centered on the nanosecond pulsed laser ablation of a synthetic hydroxyapatite (HAp) target, physically modified through the incorporation of metallic copper filaments, which serve as a localized dopant source during the deposition process. This configuration enables the controlled co-deposition of hydroxyapatite and copper species, facilitating the formation of uniform thin films with potential bioactive properties. The proposed protocol comprises the following key elements: • &lt;b&gt;Preparation of Targets:&lt;/b&gt; A comprehensive, stepwise procedure for the synthesis of hydroxyapatite powder and the subsequent fabrication of mechanically robust ceramic targets, including a novel approach for embedding copper filaments to ensure effective doping during laser ablation. • &lt;b&gt;Deposition Parameters:&lt;/b&gt; Detailed specifications of the PAPLD system, encompassing laser characteristics (wavelength, fluence, repetition rate), target-to-substrate distance, and chamber vacuum conditions. These parameters have been optimized to ensure reproducibility in film growth and compositional consistency. • &lt;b&gt;Validation Procedure:&lt;/b&gt; A systematic approach to validating the deposition process, focused on confirming the incorporation of copper into the hydroxyapatite matrix and verifying the formation of crystalline HAp-Cu films through targeted characterization techniques, distinct from exhaustive physicochemical or biological evaluations. The methodology described herein establishes a reliable framework for the fabrication of HAp-Cu coatings via PAPLD, offering a reproducible route for future studies requiring precise control over dopant incorporation within hydroxyapatite-based thin films. For further details regarding the physicochemical characterization and biological assessment of the resulting coatings, the reader is referred to a complementary publication by the authors.&lt;/p&gt;&lt;/div&gt;</dc:description>
          <dc:date>2026-09-25T17:46:27Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0358441.s003</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Data_PLOS_p_/33999864</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
